课题基金 / 基金详情

Understanding the Epithelial Site-Specific Origin of HPV Neoplasia and its Control

Understanding the Epithelial Site-Specific Origin of HPV Neoplasia and its Control
了解 HPV 肿瘤的上皮位点特异性起源及其控制
批准号:
MR/S024409/1
负责人:
John Doorbar
金额:
$74.53万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

John Doorbar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human papillomaviruses cause a wide range of problematic lesions, including a significant number of human cancers, as well as genital warts, respiratory papillomas, and recalcitrant skin lesions. The cancer-associated HPV types are often referred to as 'high-risk' types and are responsible for about 6% of all human cancers, with cervical cancer being the most significant of these. Cervical cancer is the most common cancer to affect young women, and causes approximately a quarter of a million deaths per year worldwide. High risk HPVs can also cause oropharyngeal, anal and penile cancer. There are currently no antiviral therapies that can cure either high or low-risk HPV-associated disease, although since 2008, vaccines have been available in the UK that protect against some high and some low-risk HPV types. Cervical cancer is also managed with cervical screening, with 'precancerous lesions' being surgically excised if they are detected. Neither vaccination nor screening are totally effective in preventing disease, and are still not widely implemented worldwide. A significant part of our work addresses 'vulnerable epithelial sites' such as the uterine cervix, where high risk HPV types cause pre-cancers and cancers. We suspect that viral gene expression can be disrupted at these epithelial sites from the outset, with this deregulation having a major influence on cancer risk. Our main priority is to examine how site-specific deregulated human papillomaviruses gene expression can lead to disease. We will compare viral gene expression and the target cell primarily at the cervix and then at the various other vulnerable sites within the body. We will also examine viral gene expression in relation to the immune system components during subclinical infection, compared with active infections, regressing lesions and de novo infections. Our combined approach aims to understand more accurately the biology of disease progression, to underpin future developments in screening and potential treatments.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Mouse Papillomavirus L1 and L2 Are Dispensable for Viral Infection and Persistence at Both Cutaneous and Mucosal Tissues.
小鼠乳头瘤病毒 L1 和 L2 对于皮肤和粘膜组织的病毒感染和持续存在是可有可无的。
DOI: 10.17863/cam.77536
发表时间: 2021
期刊:
影响因子: --
作者: [Brendle S]
通讯作者: Brendle S
DOI: 10.1016/j.ebiom.2020.103177
发表时间: 2021-01
期刊: EBioMedicine
影响因子: 11.1
作者: [Egawa N, Shiraz A, Crawford R, Saunders-Wood T, Yarwood J, Rogers M, Sharma A, Eichenbaum G, Doorbar J]
通讯作者: Doorbar J
DOI: 10.1016/j.cell.2021.06.004
发表时间: 2021-07-08
期刊: Cell
影响因子: 64.5
作者: [Béziat V, Rapaport F, Hu J, Titeux M, Bonnet des Claustres M, Bourgey M, Griffin H, Bandet É, Ma CS, Sherkat R, Rokni-Zadeh H, Louis DM, Changi-Ashtiani M, Delmonte OM, Fukushima T, Habib T, Guennoun A, Khan T, Bender N, Rahman M, About F, Yang R, Rao G, Rouzaud C, Li J, Shearer D, Balogh K, Al Ali F, Ata M, Dabiri S, Momenilandi M, Nammour J, Alyanakian MA, Leruez-Ville M, Guenat D, Materna M, Marcot L, Vladikine N, Soret C, Vahidnezhad H, Youssefian L, Saeidian AH, Uitto J, Catherinot É, Navabi SS, Zarhrate M, Woodley DT, Jeljeli M, Abraham T, Belkaya S, Lorenzo L, Rosain J, Bayat M, Lanternier F, Lortholary O, Zakavi F, Gros P, Orth G, Abel L, Prétet JL, Fraitag S, Jouanguy E, Davis MM, Tangye SG, Notarangelo LD, Marr N, Waterboer T, Langlais D, Doorbar J, Hovnanian A, Christensen N, Bossuyt X, Shahrooei M, Casanova JL]
通讯作者: Casanova JL
DOI: 10.1007/s10147-023-02340-y
发表时间: 2023-08
期刊: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
影响因子: 3.3
作者: [Egawa, Nagayasu]
通讯作者: Egawa, Nagayasu
Molecular Biology of Human Papillomavirus Infection 2
  • 批准号:
    MC_PC_13050
  • 项目类别:
    Intramural
  • 资助金额:
    $184.46万
  • 财政年份:
    2013
  • 负责人:
    John Doorbar
  • 依托单位:
海外基金